Phase I trial investigating the tolerability of elpamotide
Latest Information Update: 26 Oct 2010
At a glance
- Drugs Elpamotide (Primary)
- Indications Biliary cancer; Pancreatic cancer
- Focus Adverse reactions
- Sponsors Fuso Pharmaceutical Industries; OncoTherapy Science
- 27 Apr 2006 New trial record.